about
Chiral MEKC-LIF of amino acids in foods: analysis of vinegars.Quantitation of chiral amino acids from microalgae by MEKC and LIF detection.Enantioselective determination by capillary electrophoresis with cyclodextrins as chiral selectors.Recent applications in nanoliquid chromatography.Chiral separations by CE employing CDs.Food analysis: a continuous challenge for miniaturized separation techniques.Chiral capillary electrophoresis in food analysis.Advances in the enantioseparation of β-blocker drugs by capillary electromigration techniques.Enantiomeric separations by means of nano-LC.Current applications of miniaturized chromatographic and electrophoretic techniques in drug analysis.Controlling enantioselectivity in chiral capillary electrophoresis with inclusion-complexation.Nano-liquid chromatography analysis of dansylated biogenic amines in wines.CEC-ESI ion trap MS of multiple drugs of abuse.Coupling capillary electrochromatography with mass spectrometry by using a liquid-junction nano-spray interface.Analysis of hesperetin enantiomers in human urine after ingestion of blood orange juice by using nano-liquid chromatography.Optical isomer separation of flavanones and flavanone glycosides by nano-liquid chromatography using a phenyl-carbamate-propyl-beta-cyclodextrin chiral stationary phase.Nano-liquid chromatography and capillary electrochromatography hyphenated with mass spectrometry for tryptic digest protein analysis: a comparison.Enantiomeric separation of dihydroxyphenylalanine (DOPA), methyldihydroxyphenylalanine (MDOPA) and hydrazinomethyldihydroxyphenylalanine (CDOPA) by using capillary electrophoresis with sulfobutyl ether-beta-cyclodextrin as a chiral selector.Separation of multicomponent mixtures of 2,4-dinitrophenyl labelled amino acids and their enantiomers by capillary zone electrophoresis.Use of vancomycin silica stationary phase in packed capillary electrochromatography I. Enantiomer separation of basic compounds.Rapid capillary electrophoretic method for the determination of clozapine and desmethylclozapine in human plasma.Use of vancomycin silica stationary phase in packed capillary electrochromatography. II. Enantiomer separation of venlafaxine and O-desmethylvenlafaxine in human plasma.Chiral analysis of UV nonabsorbing compounds by capillary electrophoresis using macrocyclic antibiotics: 1. Separation of aspartic and glutamic acid enantiomers.Analysis of reboxetine, a novel antidepressant drug, in pharmaceutical tablets by capillary electrophoresis and derivative spectrophotometry.Use of vancomycin silica stationary phase in packed capillary electrochromatography: III. enantiomeric separation of basic compounds with the polar organic mobile phase.Separation of delta-, gamma- and alpha-tocopherols by CEC.Determination of losartan and hydrochlorothiazide in tablets by CE and CEC.An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate.Separation of reboxetine enantiomers by means of capillary electrophoresis.Enantiomers resolution in capillary zone electrophoresis by using cyclodextrins.Enantioseparation of amino acid derivatives by capillary zone electrophoresis using vancomycin as chiral selector.HPLC analysis of the novel antipsychotic drug quetiapine in human plasma.A glycopeptide antibiotic chiral stationary phase for the enantiomer resolution of hydroxy acid derivatives by capillary electrochromatography.Use of short-end injection capillary packed with a glycopeptide antibiotic stationary phase in electrochromatography and capillary liquid chromatography for the enantiomeric separation of hydroxy acids.Medium effect (transfer activity coefficient) of methanol and acetonitrile on beta-cyclodextrin/benzoate complexation in capillary zone electrophoresis.Enantiomeric separation of acidic compounds of pharmaceutical interest by capillary electrochromatography employing glycopeptide antibiotic stationary phases.Enantiomeric separation of citalopram and its metabolites by capillary electrophoresis.Evaluation of teicoplanin chiral stationary phases of 3.5 and 5 microm inside diameter silica microparticles by polar-organic mode capillary electrochromatography.Ibuprofen quality control by electrochromatography.Fast-liquid chromatography using columns of different internal diameters packed with sub-2 μm silica particles.
P50
Q33245015-29275FA8-9242-4A12-A2A6-2A54E8386063Q33288858-33CB58F2-756D-4817-B675-516F7AE3A0C0Q33934754-F4739BDF-6B6E-46DE-BF94-C8C43CAAE832Q36876426-61322D7B-DFA7-451D-9912-444C7DFFA0B7Q37515106-44E76BEA-D0F3-4975-88F6-3BFBB6D80D42Q37624586-D724D821-1BB5-4406-9B0B-6D1FA7DFE216Q37763652-6B9D515C-1E84-445F-8099-DD0DCE282CB4Q37929662-F2DD9A3B-CC6D-430B-97B4-B476BFD639BCQ38071986-905D77E2-F716-416B-B802-38088F02696BQ38208374-81CED166-E023-49E5-ACE3-E53118439AF2Q41701018-8C3F5296-BB61-4143-B240-6CA28E952813Q42164747-E07AAD7A-D184-471F-A1DB-71E4B47B75C0Q43139869-BFD31F94-0974-45C6-8B63-7C23F9A8B9ABQ43234261-EB636A21-B656-4175-9903-A1025600BAAFQ43278929-AEFFB0F0-53B3-4237-80BF-B1DC9441EC82Q43287836-42905A0A-DCFE-4EA8-BE51-811A458A90D5Q43418572-D555ACB3-C6FF-4A6E-8188-4A3BD3A0349AQ43507458-6B54AE76-FC53-4799-B285-9134F433ED0CQ43547491-B8C17443-F44D-4EE1-A45A-A2223F70F893Q43547513-91BC9519-C548-4C7F-9E53-7C18F5E8448CQ43623785-E0BC365F-748C-4F3D-A0E8-D7B916842E27Q43679540-A30FA7E1-755B-4B2E-A05D-A8DF2F0D6724Q43706233-E6B8D4AB-D29D-4596-B257-728CD561CEBFQ43781142-0582C368-2453-4BAB-B2D3-71679F95C71CQ43900202-1E6775AC-05C6-4149-B3CC-A58E1A468D6EQ44058023-E6137FE2-F318-404E-B2EB-9E8E3CB47B8EQ44058027-C37A25CD-F06F-429C-B68C-50BBF7779D60Q44058030-452EA0B5-2D05-45CE-AFA2-D405AB735C40Q44063061-8408C9B5-19D4-4778-9127-0F47E8206C76Q44067084-2E1A7CB7-4F72-44AC-B5B5-BC495DEE84FDQ44122397-EF751515-A153-40AF-8201-F9FAAACA2A48Q44199651-0E4998B4-FEEE-4A2E-9A87-D563892CD2FBQ44355992-56A1514E-D8F6-47B9-B23E-2E192C56AC8FQ44396997-13912478-BB04-4A44-8593-02D2170EE433Q44410051-DF4D307D-8B89-4FEC-AE86-A82311D66FEAQ44461235-1A6C62A6-9F72-48B0-B880-C6082D542908Q44538480-B9BD5AD0-AA2A-4D66-AE96-837FE9EB6865Q44584618-F1942601-A6F0-44B4-9B30-80F293856C2CQ44588315-8D085EA5-50CC-4369-A5C7-E14D8164DE03Q44591833-593C6CA4-A986-4A85-A6ED-37431E28C08A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Salvatore Fanali
@ast
Salvatore Fanali
@en
Salvatore Fanali
@es
Salvatore Fanali
@nl
Salvatore Fanali
@sl
type
label
Salvatore Fanali
@ast
Salvatore Fanali
@en
Salvatore Fanali
@es
Salvatore Fanali
@nl
Salvatore Fanali
@sl
altLabel
Salvatore Fanali
@en
prefLabel
Salvatore Fanali
@ast
Salvatore Fanali
@en
Salvatore Fanali
@es
Salvatore Fanali
@nl
Salvatore Fanali
@sl
P214
P244
P106
P1153
55154022900
7006614492
P21
P213
0000 0003 9984 6892
P214
P244
n2013180614
P31
P496
0000-0002-8221-6133
P735
P7859
lccn-n2013180614